Provide feedbackProvide feedback
Home :: Psychiatry

Mayo Clinic data highlight risk of new-onset compulsive gambling, hypersexuality among patients with PD who receive dopamine agonists

Wednesday, April 15 2009 | Comments
Evidence Grade 3 What's This?

A retrospective analysis of patients with Parkinson's disease (PD) treated at the Mayo Clinic in Rochester, Minnesota, shows new-onset compulsive gambling and hypersexuality occurring exclusively among those who received therapeutic doses of dopamine agonists, with such behaviors remitting when the drugs were discontinued or dosages were reduced. Researchers reviewed the medical records of 267 patients with PD who resided in the 7 counties surrounding the Rochester clinic and were treated...

A retrospective analysis of patients with Parkinson's disease (PD) treated at the Mayo Clinic in Rochester, Minnesota, shows new-onset compulsive gambling and hypersexuality occurring exclusively among those who received therapeutic doses of dopamine agonists, with such behaviors remitting when the drugs were discontinued or dosages were reduced.

Researchers reviewed the medical records of 267 patients with PD who resided in the 7 counties surrounding the Rochester clinic and were treated in the neurology department between July 1, 2004, and June 30, 2006. The main outcome of the analysis was documentation of compulsive gambling or hypersexuality developing after the onset of parkinsonism, with consideration given to the temporal relationship between the onset of the behavior and the start of drug therapy for PD.

New-onset gambling or hypersexuality was documented in 7 patients (2.6%).

All of these cases were among the 66 patients who were taking a dopamine agonist (10.6% of all dopamine agonist users). Moreover, all 7 patients were among the 38 patients who were receiving a therapeutic dopamine agonist dose (18.4%), defined as >=2 mg/day of pramipexole or >=6 mg/d of ropinirole. Five of the 7 patients were taking concomitant levodopa/carbidopa.

Of these 7 patients, 5 demonstrated behaviors that the researchers characterized as "clearly pathologic and disabling," yielding a prevalence for pathologic behavior of 7.6% among all dopamine agonist users and 13.2% among those receiving a therapeutic dose. Among these 5 patients, 2 received treatment for a primary psychiatric condition before the connection with dopamine agonist use was identified.

None of the 7 patients was receiving a dopamine agonist dosage that exceeded the usual recommended dosage, the authors noted. In all 7 patients, the problematic behaviors abated when the dopamine agonist was discontinued or the dosage was reduced.

The investigators acknowledged that this study was not truly a community-based design, in that there was potential for selection bias, but they assumed that the majority of patients in the counties surrounding the Mayo Clinic would have sought treatment there because of the clinic's proximity and the lack of alternative resources.

They further acknowledged that because of the retrospective nature of the analysis, cases of compulsive gambling and hypersexuality might have been missed, particularly in light of the reluctance by patients and physicians to report and document such behavior and a general lack of awareness of the potential for such behavior with dopamine agonist use. As a result, they noted, these results likely underestimate the true frequency of these behaviors. They added that these factors might also explain why these behaviors were not documented in clinical trials of pramipexole and ropinirole. (Bostwick JM, et al. Mayo Clin Proc 2009;84:310-316.)

Latest News

FDA alert regarding suicidality with AEDs receives low marks from neurologists; nearly half say it will not influence their practice Verusmed

Wednesday, April 01 2009 | Comments
Evidence Grade 9 What's This?
Results of a recent survey suggest that the Food and Drug Administration alert about an increased risk of suicidality with antiepileptic drugs (AEDs) was not well-received by neurology practitioners, with 46% of the respondents stating that it would not influence their clinical practice.

The FDA issued an alert in January of last year stating that AEDs were associated with an increased risk of...
Tags: Epilepsy


Diabetes associated with increased risk of perinatal depression in low-income mothers, Medicaid data show Verusmed

Wednesday, March 11 2009 | Comments
Evidence Grade 11 What's This?
Among low-income mothers, prepregnancy and gestational diabetes are associated with an increased risk of depression during the perinatal period, according to an analysis of New Jersey Medicaid data.

As part of a retrospective cohort study, researchers reviewed Medicaid data for 11,024 women who gave birth between July 1, 2004, and Sept. 30, 2006; all of the women included in the study were enrolled in Medicaid for >=6 months prior to and 1 year following the birth.


Undiagnosed depression constitutes nearly half of all depression cases in patients with diabetes, results indicate Verusmed

Wednesday, February 25 2009 | Comments
Evidence Grade 9 What's This?
Among individuals with diabetes, approximately 45% of depression cases have not been diagnosed, according to an analysis of data for U.S. adults included in the 2006 Behavioral Risk Factor Surveillance System (BRFSS) survey.

As part of the 2006 BRFSS survey, depression and anxiety were assessed with the 8-item Primary Care Evaluation of Mental Disorders Health Questionnaire (PHQ-8). The PHQ-8, the study authors noted, contains questions that address 8 of the 9 DSM-IV criteria...

New study shows no link between insomnia, incident hypertension in older adults Verusmed

Tuesday, February 17 2009 | Comments
Evidence Grade 3 What's This?
New data do not support the notion that insomnia increases the risk of developing hypertension in older adults. In fact, findings from the study actually showed a reduced risk of incident hypertension among nonblack men who reported difficulty initiating sleep at baseline.

The study researchers hypothesized that insomnia complaints would predict the development of hypertension, particularly among black individuals. They cited a longitudinal analysis that revealed a link between...
Tags: Insomnia






Psychiatry Conference Coverage